Display options
Cite
Kotta S, Aldawsari HM, Badr-Eldin SM, et al. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives. Front Mol Biosci. 2020;7:606393doi: 10.3389/fmolb.2020.606393.
Kotta, S., Aldawsari, H. M., Badr-Eldin, S. M., Alhakamy, N. A., Md, S., Nair, A. B., & Deb, P. K. (2020). Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives. Frontiers in molecular biosciences, 7606393. https://doi.org/10.3389/fmolb.2020.606393
Kotta, Sabna, et al. "Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives." Frontiers in molecular biosciences vol. 7 (2020): 606393. doi: https://doi.org/10.3389/fmolb.2020.606393
Kotta S, Aldawsari HM, Badr-Eldin SM, Alhakamy NA, Md S, Nair AB, Deb PK. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives. Front Mol Biosci. 2020 Nov 17;7:606393. doi: 10.3389/fmolb.2020.606393. eCollection 2020. PMID: 33282914; PMCID: PMC7705351.
Copy Download .nbib Format: NLM
Share it on

Front Mol Biosci. 2020 Nov 17;7:606393. doi: 10.3389/fmolb.2020.606393. eCollection 2020.

Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives.

Frontiers in molecular biosciences

Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M Badr-Eldin, Nabil Abdulhafiz Alhakamy, Shadab Md, Anroop B Nair, Pran Kishore Deb

Affiliations

  1. Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  2. Department of Pharmaceutics and Industrial Pharmacy, Cairo University, Cairo, Egypt.
  3. Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
  4. Department of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, Amman, Jordan.

PMID: 33282914 PMCID: PMC7705351 DOI: 10.3389/fmolb.2020.606393

Abstract

The coronavirus disease-19 (COVID-19) is caused due to the infection by a unique single stranded enveloped RNA virus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The COVID-19 has claimed many lives around the globe, and a promising solution to end this pandemic is still awaited. Till date neither an exact antiviral drug nor a vaccine is available in the market for public use to cure or control this pandemic. Repurposed drugs and supportive measures are the only available treatment options. This systematic review focuses on different treatment strategies based on various clinical studies. The review discusses all the current treatment plans and probable future strategies obtained as a result of a systematic search in PubMed and Science Direct database. All the possible options for the treatment as well as prophylaxis of COVID-19 are discussed. Apart from this, the article provides details on the clinical trials related to COVID-19, which are registered under ClinicalTrials.gov. Potential of drugs based on the previous researches on SARS-CoV, MERS-CoV, Ebola, influenza, etc. which fall under the same category of coronavirus are also emphasized. Information on cell-based and immunology-based approaches is also provided. In addition, miscellaneous therapeutic approaches and adjunctive therapies are discussed. The drug repurposing options, as evidenced from various

Copyright © 2020 Kotta, Aldawsari, Badr-Eldin, Alhakamy, Md, Nair and Deb.

Keywords: COVID-19; SARS-CoV-2; convalescent plasma therapy; drug repurposing; vaccine

References

  1. Infez Med. 2020 Ahead of print Jun 1;28(2):143-152 - PubMed
  2. Emerg Microbes Infect. 2020 Dec;9(1):382-385 - PubMed
  3. Cytotherapy. 2020 Nov;22(11):602-605 - PubMed
  4. Am J Respir Crit Care Med. 1996 Jul;154(1):57-62 - PubMed
  5. Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3390-3396 - PubMed
  6. J Chem Inf Model. 2012 Oct 22;52(10):2715-29 - PubMed
  7. Cureus. 2020 Aug 3;12(8):e9535 - PubMed
  8. Lancet. 2020 Feb 22;395(10224):565-574 - PubMed
  9. Acta Pharm Sin B. 2020 May;10(5):766-788 - PubMed
  10. Antiviral Res. 2014 Jul;107:84-94 - PubMed
  11. Antiviral Res. 2020 Jun;178:104786 - PubMed
  12. N Engl J Med. 2020 May 7;382(19):1787-1799 - PubMed
  13. J Clin Invest. 2020 Jun 1;130(6):2757-2765 - PubMed
  14. N Engl J Med. 2020 Mar 26;382(13):1199-1207 - PubMed
  15. Med Hypotheses. 2020 Sep;142:109814 - PubMed
  16. Antiviral Res. 2020 Jun;178:104793 - PubMed
  17. Int J Antimicrob Agents. 2020 May;55(5):105954 - PubMed
  18. Drug Discov Ther. 2020;14(1):58-60 - PubMed
  19. Swiss Med Wkly. 2020 Apr 11;150:w20246 - PubMed
  20. Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6 - PubMed
  21. Curr Med Chem. 2020 Sep 08;: - PubMed
  22. Biosci Trends. 2020 Mar 16;14(1):64-68 - PubMed
  23. Eur J Clin Invest. 2020 Mar;50(3):e13209 - PubMed
  24. Life Sci. 2020 Jul 1;252:117652 - PubMed
  25. Int J Infect Dis. 2020 Apr;93:297-299 - PubMed
  26. Viruses. 2020 Apr 26;12(5): - PubMed
  27. Med Hypotheses. 2020 Jul;140:109762 - PubMed
  28. Int J Antimicrob Agents. 2020 Aug;56(2):106080 - PubMed
  29. Med Hypotheses. 2020 Oct;143:110081 - PubMed
  30. Cell Res. 2020 Mar;30(3):269-271 - PubMed
  31. Nat Commun. 2020 May 4;11(1):2251 - PubMed
  32. Clin Pharmacol Ther. 2020 Aug;108(2):242-247 - PubMed
  33. Antiviral Res. 2020 May;177:104762 - PubMed
  34. Clin Infect Dis. 2020 Jul 28;71(15):732-739 - PubMed
  35. Med Hypotheses. 2020 Jul;140:109755 - PubMed
  36. Med Hypotheses. 2020 Oct;143:109843 - PubMed
  37. Clin Infect Dis. 2003 Jun 15;36(12):1585-92 - PubMed
  38. Sci Total Environ. 2020 Jul 10;725:138277 - PubMed
  39. Int Immunopharmacol. 2010 Jul;10(7):744-50 - PubMed
  40. Int J Antimicrob Agents. 2020 May;55(5):105938 - PubMed
  41. Clin Infect Dis. 2020 Jul 28;71(15):769-777 - PubMed
  42. Biosci Trends. 2020 Mar 16;14(1):72-73 - PubMed
  43. J Med Virol. 2020 Apr;92(4):401-402 - PubMed
  44. J Med Virol. 2020 Apr;92(4):433-440 - PubMed
  45. Lancet. 2020 Feb 15;395(10223):e30-e31 - PubMed
  46. J Med Virol. 2020 Jul;92(7):814-818 - PubMed
  47. J Pharm Anal. 2020 Apr;10(2):102-108 - PubMed
  48. J Infect. 2020 Jul;81(1):e1-e5 - PubMed
  49. J Transl Med. 2020 Apr 14;18(1):165 - PubMed
  50. Biosci Trends. 2020 Mar 16;14(1):69-71 - PubMed
  51. Dermatol Ther. 2020 Jul;33(4):e13383 - PubMed
  52. Nat Nanotechnol. 2020 Apr;15(4):247-249 - PubMed
  53. Int J Antimicrob Agents. 2020 May;55(5):105967 - PubMed
  54. Pathogens. 2020 Apr 22;9(4): - PubMed
  55. JAMA. 2020 Apr 28;323(16):1582-1589 - PubMed
  56. Medicine (Baltimore). 2020 Jul 31;99(31):e21429 - PubMed
  57. Med Hypotheses. 2020 Sep;142:109815 - PubMed
  58. BMJ. 2020 Mar 26;368:m1256 - PubMed
  59. Cell Discov. 2020 Mar 18;6:16 - PubMed
  60. J Autoimmun. 2020 May;109:102442 - PubMed
  61. J Korean Med Sci. 2020 Feb 17;35(6):e79 - PubMed
  62. Med Hypotheses. 2020 Sep;142:109828 - PubMed
  63. Chin Med J (Engl). 2020 May 5;133(9):1015-1024 - PubMed
  64. N Engl J Med. 2020 Mar 5;382(10):929-936 - PubMed
  65. Science. 2020 Mar 27;367(6485):1412-1413 - PubMed
  66. J Biomol Struct Dyn. 2020 Apr 16;:1-6 - PubMed
  67. Nature. 2020 Apr 29;: - PubMed
  68. Int J Environ Res Public Health. 2020 Apr 23;17(8): - PubMed
  69. Med Drug Discov. 2020 Jun;6:100039 - PubMed
  70. J Travel Med. 2020 Mar 13;27(2): - PubMed
  71. Ann Oncol. 2020 Jul;31(7):961-964 - PubMed
  72. Front Med (Lausanne). 2020 May 22;7:254 - PubMed
  73. IEEE Rev Biomed Eng. 2020 Apr 27;PP: - PubMed
  74. Aging Dis. 2020 Mar 9;11(2):216-228 - PubMed
  75. Lancet Respir Med. 2020 Mar;8(3):e11-e12 - PubMed
  76. Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776 - PubMed
  77. Clin Microbiol Infect. 2004 Jul;10(7):676-8 - PubMed
  78. Ir Med J. 2020 Apr 03;113(4):58 - PubMed
  79. Oral Oncol. 2020 Jul;106:104659 - PubMed
  80. Int J Infect Dis. 2020 Mar;92:214-217 - PubMed
  81. Lancet Infect Dis. 2020 Apr;20(4):398-400 - PubMed
  82. J Biol Chem. 2020 Apr 10;295(15):4773-4779 - PubMed
  83. J Pharm Anal. 2020 Aug;10(4):313-319 - PubMed
  84. Viruses. 2018 May 30;10(6): - PubMed
  85. J Korean Med Sci. 2020 Apr 13;35(14):e149 - PubMed
  86. J Med Virol. 2020 Sep;92(9):1549-1555 - PubMed
  87. J Microbiol Immunol Infect. 2020 Jun;53(3):436-443 - PubMed
  88. Med Hypotheses. 2020 Apr 22;140:109765 - PubMed
  89. Diabetes Metab Syndr. 2020 May - Jun;14(3):241-246 - PubMed
  90. Antiviral Res. 2020 Jun;178:104787 - PubMed
  91. J Autoimmun. 2020 May;109:102433 - PubMed
  92. Life Sci. 2020 Jul 15;253:117592 - PubMed
  93. Virol J. 2005 Aug 22;2:69 - PubMed
  94. Int J Antimicrob Agents. 2020 Mar;55(3):105923 - PubMed
  95. Pharmacol Res. 2020 Jul;157:104874 - PubMed
  96. Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975 - PubMed
  97. Ann Rheum Dis. 2020 May;79(5):668-669 - PubMed
  98. Rev Panam Salud Publica. 2020 Mar 20;44:e40 - PubMed
  99. J Clin Med. 2020 Apr 24;9(4): - PubMed
  100. Diagn Interv Imaging. 2020 May;101(5):323-324 - PubMed
  101. Nat Rev Microbiol. 2016 Aug;14(8):523-34 - PubMed
  102. Immunotherapy. 2020 Apr;12(5):269-273 - PubMed
  103. Lancet. 2020 Feb 15;395(10223):497-506 - PubMed
  104. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496 - PubMed
  105. Autoimmun Rev. 2020 Jul;19(7):102554 - PubMed
  106. Int J Antimicrob Agents. 2020 May;55(5):105951 - PubMed
  107. Am J Respir Crit Care Med. 2020 Feb 15;201(4):P7-P8 - PubMed
  108. Indian J Med Res. 2020 Feb & Mar;151(2 & 3):184-189 - PubMed
  109. Int J Antimicrob Agents. 2020 Jun;55(6):105964 - PubMed
  110. Curr Med Chem. 2020;27(27):4536-4541 - PubMed
  111. Life Sci. 2020 Jun 15;251:117627 - PubMed
  112. Arch Acad Emerg Med. 2020 Mar 30;8(1):e40 - PubMed
  113. J Autoimmun. 2020 Jul;111:102452 - PubMed
  114. J Clin Virol. 2020 Jun;127:104358 - PubMed
  115. Med Drug Discov. 2020 Mar;5:100019 - PubMed
  116. Med Drug Discov. 2020 Mar;5:100028 - PubMed
  117. Pharmacol Res. 2020 Jul;157:104859 - PubMed
  118. J Transl Med. 2020 Apr 14;18(1):164 - PubMed
  119. Blood Adv. 2020 Apr 14;4(7):1307-1310 - PubMed
  120. EBioMedicine. 2020 May;55:102768 - PubMed
  121. Drug Discov Today. 2020 May;25(5):928-941 - PubMed
  122. J Crit Care. 2020 Jun;57:279-283 - PubMed
  123. Am J Emerg Med. 2020 Mar 24;: - PubMed
  124. Med Hypotheses. 2020 Sep;142:109826 - PubMed
  125. Cytokine Growth Factor Rev. 2020 Jun;53:25-32 - PubMed
  126. Med Hypotheses. 2020 Sep;142:109835 - PubMed
  127. N Engl J Med. 2020 Apr 16;382(16):1564-1567 - PubMed
  128. Comput Struct Biotechnol J. 2020 Mar 30;18:784-790 - PubMed
  129. Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 14;43(0):E012 - PubMed
  130. Int J Antimicrob Agents. 2020 May;55(5):105955 - PubMed
  131. Inflamm Res. 2020 Jun;69(6):599-606 - PubMed
  132. Cell. 2020 Apr 16;181(2):271-280.e8 - PubMed
  133. Radiology. 2020 Apr;295(1):18 - PubMed
  134. Antiviral Res. 2020 Jun;178:104791 - PubMed
  135. Antivir Ther. 2016;21(5):455-9 - PubMed
  136. EMBO Mol Med. 2020 Aug 7;12(8):e12697 - PubMed
  137. Clin Exp Med. 2020 Nov;20(4):493-506 - PubMed
  138. JAMA. 2020 Apr 28;323(16):1561-1562 - PubMed
  139. Int Immunopharmacol. 2008 Feb;8(2):341-50 - PubMed
  140. BMC Nephrol. 2019 Nov 28;20(1):438 - PubMed
  141. Biol Blood Marrow Transplant. 2020 Jul;26(7):1239-1246 - PubMed
  142. Int J Antimicrob Agents. 2020 Jul;56(1):105949 - PubMed
  143. Infect Genet Evol. 2012 Aug;12(6):1275-81 - PubMed

Publication Types